Puerto, Colombia

Elkin Navarro


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elkin Navarro: Innovator in Immunology

Introduction

Elkin Navarro is a notable inventor based in Puerto, Colorado. He has made significant contributions to the field of immunology, particularly in the design and synthesis of synthetic oligopeptides. His work focuses on the detection of intradomiciliary mites, which are known allergens that can affect human health.

Latest Patents

Elkin Navarro holds a patent for "Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of polyclonal IgY antibodies for the detection of intradomiciliary mites." This invention involves the design, synthesis, and evaluation of six synthetic oligopeptides derived from the T and B epitopes of allergens from intradomiciliary mites. These oligopeptides can be utilized in immunomodulation for individuals with immunocompetent systems and in the production of IgY polyclonal antibodies. The patent outlines two methods: one for obtaining a cost-effective and highly reactive IgY polyclonal antibody composition for diagnostic purposes, and another for detecting mite allergens using this antibody composition.

Career Highlights

Throughout his career, Elkin Navarro has worked with esteemed institutions such as Fundación Universidad Del Norte and Pontificia Universidad Javeriana. His experience in these organizations has contributed to his expertise in immunology and patent development.

Collaborations

Elkin has collaborated with notable colleagues, including Luis Alejandro Barrera and Eduardo Egea. Their joint efforts have further advanced research in the field of immunology.

Conclusion

Elkin Navarro's innovative work in the development of synthetic oligopeptides and IgY polyclonal antibodies represents a significant advancement in the detection of intradomiciliary mites. His contributions to immunology continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…